Literature DB >> 1812347

The magnetic properties of some materials affecting MR images.

L Josephson1, J Bigler, D White.   

Abstract

We have compared the magnetic properties of various types of materials known to affect MR images. The materials compared were: (i) MR contrast agents based on chelates of paramagnetic metals (Gd-DTPA, Dy-DTPA); (ii) biological forms of iron (horse spleen ferritin and deoxyhemoglobin); and (iii) a superparamagnetic iron oxide (AMI-25). The properties compared were the magnetic susceptibility and the magnetization. The magnetization and susceptibility of superparamagnetic AMI-25 are far larger than that of ferritin or low molecular weight, paramagnetic chelates. Superparamagnetic iron oxide colloids, like AMI-25, are a uniquely powerful class of magnetic materials.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812347     DOI: 10.1002/mrm.1910220208

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  4 in total

1.  Magnetic resonance imaging of the rat Harderian gland.

Authors:  Andrea Sbarbati; Laura Calderan; Elena Nicolato; Pasquina Marzola; Ernesto Lunati; Benati Donatella; Paolo Bernardi; Francesco Osculati
Journal:  J Anat       Date:  2002-09       Impact factor: 2.610

2.  Effect of spatial distribution of magnetic dipoles on Lamor frequency distribution and MR Signal decay--a numerical approach under static dephasing conditions.

Authors:  J Pintaske; B Müller-Bierl; F Schick
Journal:  MAGMA       Date:  2006-02-10       Impact factor: 2.310

3.  Susceptibility-based MRI contrast of the CSF by intravascular superparamagnetic nanoparticles.

Authors:  O Yu; I J Namer; J Steibel; B Eclancher; P Poulet; J Chambron
Journal:  MAGMA       Date:  1995 Sep-Dec       Impact factor: 2.310

Review 4.  Cancer theranostics: the rise of targeted magnetic nanoparticles.

Authors:  Adam J Cole; Victor C Yang; Allan E David
Journal:  Trends Biotechnol       Date:  2011-04-12       Impact factor: 19.536

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.